Emel Bulbul Baskan
Overview
    Explore the profile of Emel Bulbul Baskan including associated specialties, affiliations and a list of published articles.
           
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              50
            
            
              Citations
              252
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          
        
        
        
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Dilektasli A, Durak V, Armagan E, Korkmaz E, Kiras G, Sen A, et al.
  
  
    Risk Manag Healthc Policy
    . 2025 Feb;
          18:579-592.
    
    PMID: 40008028
  
  
          Purpose: Pandemics put healthcare workers (HCWs) at risk of infections, making emergency department (ED) triage critical. This study aims to compare smart innovative self-kiosk triage (SKT) with routine triage (RT)....
      
2.
        
    
    Engin B, Guler Ozden M, Bakay O, Kartal S, Zindanci I, Cinar S, et al.
  
  
    Dermatol Ther (Heidelb)
    . 2024 Nov;
          14(12):3337-3350.
    
    PMID: 39578347
  
  
          Introduction: Topical therapies are used in almost all patients with psoriasis. A novel fixed topical combination cream (GN-037) with a lower concentration (0.0356%) of clobetasol 17-propionate (CP) was developed together...
      
3.
        
    
    Alpsoy E, Fettahlioglu Karaman B, Demirseren D, Cinar S, Kacar N, Ermertcan A, et al.
  
  
    Dermatology
    . 2024 Nov;
          1-11.
    
    PMID: 39571540
  
  
          Introduction: The natural history, the progression of a disease process in an individual over time, has not yet been fully elucidated in hidradenitis suppurativa (HS). In this large multicenter study,...
      
4.
        
    
    Yuce B, Kalay O, Karpat F, Alemdar A, Temel S, Dilektasli A, et al.
  
  
    J Environ Health Sci Eng
    . 2024 Oct;
          22(2):471-482.
    
    PMID: 39464828
  
  
          The novel coronavirus (SARS-CoV-2) outbreak has spread worldwide, and the World Health Organization (WHO) declared a global pandemic in March 2020. The transmission mechanism of SARS-CoV-2 in indoor environments has...
      
5.
        
    
    Askin O, Engin B, Ozdede A, Kartal S, Ugurlu S, Ozkok Akbulut T, et al.
  
  
    Medicine (Baltimore)
    . 2024 Jul;
          103(29):e38832.
    
    PMID: 39029037
  
  
          Psoriasis is a common multisystem inflammatory disease, and arthritis is an essential component of the disorder, requiring early diagnosis and prompt treatment for successful management. In this study, we aimed...
      
6.
        
    
    Erduran F, Adisen E, Emre S, Hayran Y, Bulbul Baskan E, Yazici S, et al.
  
  
    Dermatol Ther (Heidelb)
    . 2024 May;
          14(6):1547-1560.
    
    PMID: 38758423
  
  
          Introduction: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening acute mucocutaneous disorders usually triggered by drugs. In this study, we aimed to evaluate the factors affecting mortality in...
      
7.
        
    
    Bilgic A, Fettahlioglu Karaman B, Demirseren D, Cinar L, Kacar N, Ermertcan A, et al.
  
  
    Dermatology
    . 2023 Jan;
          239(3):445-453.
    
    PMID: 36702103
  
  
          Background: Hidradenitis suppurativa (HS) causes significant physical, social, and psychological burdens. Internalized stigma, acceptance of negative attitudes and stereotypes of society regarding a person's illness, has not been studied previously...
      
8.
        
    
    Hasal E, Bulbul Baskan E, Yazici S, Aydogan K, Saricaoglu H
  
  
    Int Arch Allergy Immunol
    . 2022 Aug;
          183(11):1198-1208.
    
    PMID: 36037806
  
  
          Introduction: This study aimed to evaluate factors affecting drug survival and treatment response in patients with chronic urticaria treated with omalizumab in clinical practice. Methods: This study included 386 patients...
      
9.
        
    
    Kocaturk E, Bulbul Baskan E, Su Kucuk O, Ozdemir M, Ornek S, Can P, et al.
  
  
    An Bras Dermatol
    . 2022 Jul;
          97(5):592-600.
    
    PMID: 35853771
  
  
          Background: Chronic Spontaneous Urticaria (CSU) is characterized by recurrent wheals and/or angioedema for longer than 6-weeks. Guidelines recommend Omalizumab (Oma) as first-line and Cyclosporine-A (Cs-A) as second-line treatment in antihistamine...
      
10.
        
    
    Hasal E, Bulbul Baskan E, Gul S, Dilektasli A, Sag S, Balaban Adim S, et al.
  
  
    Ann Dermatol
    . 2022 Feb;
          34(1):66-71.
    
    PMID: 35221599
  
  
          Birt-Hogg-Dube syndrome (BHDS) is a rare disorder characterized by the triad of cutaneous lesions, renal tumors, lung cysts and inactivation of the gene  (). Here, we present three female patients...